G. Viale

4.0k total citations · 2 hit papers
47 papers, 3.0k citations indexed

About

G. Viale is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Viale has authored 47 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Viale's work include Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (8 papers) and Advanced Breast Cancer Therapies (7 papers). G. Viale is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (8 papers) and Advanced Breast Cancer Therapies (7 papers). G. Viale collaborates with scholars based in Italy, United States and Belgium. G. Viale's co-authors include Veronica Vergani, Patrizia Borsotti, Teresa Drudis, Raffaella Giavazzi, Giulia Taraboletti, Mathew J. Ellis, Tracy Lively, Janine Salter, Daniel F. Hayes and N. Lynn Henry and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

G. Viale

41 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

2011 1.5k citations Torsten O. Nielsen, Roger A’Hern et al. JNCI Journal of the National Cancer Institute profile →
The microtubule-affecting drug paclitaxel has antiangiogenic activity.

1996 557 citations G. Viale et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Viale Italy	14	1.7k	1.4k	807	563	511	47	3.0k
Frédérique Penault–Llorca France	10	2.3k 1.4×	1.4k 1.0×	707 0.9×	734 1.3×	823 1.6×	20	3.3k
Dorthe Grabau Sweden	28	1.5k 0.9×	1.6k 1.2×	1.3k 1.7×	510 0.9×	380 0.7×	57	3.0k
Kenzo Shimazu Japan	28	1.5k 0.9×	1.6k 1.1×	977 1.2×	451 0.8×	629 1.2×	116	3.1k
Fredrik Wärnberg Sweden	30	1.2k 0.7×	1.4k 1.0×	772 1.0×	260 0.5×	682 1.3×	119	2.6k
Maysa E. El‐Sayed United Kingdom	16	1.8k 1.1×	1.9k 1.3×	812 1.0×	471 0.8×	821 1.6×	19	3.0k
Lynda Sawyer United States	13	1.5k 0.9×	1.5k 1.1×	697 0.9×	375 0.7×	552 1.1×	18	2.5k
Magali Lacroix‐Triki France	29	1.3k 0.8×	1.4k 1.0×	1.4k 1.7×	476 0.8×	648 1.3×	89	3.1k
Paul van Diest Netherlands	23	1.4k 0.9×	1.0k 0.7×	1.5k 1.8×	406 0.7×	513 1.0×	49	3.2k
Yasuaki Sagara Japan	25	1.8k 1.1×	1.2k 0.9×	422 0.5×	656 1.2×	383 0.7×	109	2.9k
Leticia De Mattos‐Arruda Spain	26	1.3k 0.8×	1.4k 1.0×	947 1.2×	735 1.3×	425 0.8×	54	2.7k

Countries citing papers authored by G. Viale

Since Specialization

Citations

This map shows the geographic impact of G. Viale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Viale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Viale more than expected).

Fields of papers citing papers by G. Viale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Viale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Viale. The network helps show where G. Viale may publish in the future.

Co-authorship network of co-authors of G. Viale

This figure shows the co-authorship network connecting the top 25 collaborators of G. Viale. A scholar is included among the top collaborators of G. Viale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Viale. G. Viale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cursano, Giulia, Mariia Ivanova, Chiara Frascarelli, et al.. (2025). Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer. Molecular Diagnosis & Therapy. 29(6). 849–857.

Vainer, Gilad W., Sunil Badve, Fernando Augusto Soares, et al.. (2025). Unraveling the complexity of PD-L1 assays: a descriptive review of the methodology, scoring, and practical implications. Frontiers in Oncology. 15. 1581275–1581275.

Metzger, Otto, Fátima Cardoso, Coralie Poncet, et al.. (2025). Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial. European Journal of Cancer. 217. 115222–115222. 3 indexed citations

Rediti, Mattia, David Venet, Marion Maetens, et al.. (2024). Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial. Nature Communications. 15(1). 10402–10402. 3 indexed citations

Fusco, Nicola & G. Viale. (2024). The “lows”: Update on ER-low and HER2-low breast cancer. The Breast. 78. 103831–103831. 7 indexed citations

Espósito, Angela, Antonio Marra, Vincenzo Bagnardi, et al.. (2021). Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis. European Journal of Cancer. 145. 197–209. 18 indexed citations

Marra, Antonio, Giulia Viale, Stefano Pileri, et al.. (2020). Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treatment Reviews. 84. 101963–101963. 54 indexed citations

Loi, Shrushma, Anita Giobbie‐Hurder, Andrea Gombos, et al.. (2017). Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014). Open Repository and Bibliography (University of Liège). 5 indexed citations

Criscitiello, Carmen, Mehra Golshan, G. Viale, et al.. (2017). Impact of neoadjuvant therapy (NT) and pathological complete response (pCR) on breast-conserving surgery (BCS) in patients (pts) with breast cancer (BC): A meta-analysis. Annals of Oncology. 28. v50–v51. 1 indexed citations

10.

Ferrari, Daris, Carla Codecà, Maria Di Blasi, et al.. (2016). Radiotherapy and cetuximab for elderly patients affected by loco-regionally advanced head and neck cancer. Annals of Oncology. 27. iv88–iv88.

11.

Fan, Li, Susanna Campagnoli, Hong Wu, et al.. (2015). Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting. Journal of Experimental & Clinical Cancer Research. 34(1). 103–103. 22 indexed citations

12.

Nielsen, Torsten O., Roger A’Hern, R. Charles Coombes, et al.. (2011). Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group. JNCI Journal of the National Cancer Institute. 103(22). 1656–1664. 1488 indexed citations breakdown →

13.

Pruneri, Giancarlo, Giovanni Mazzarol, Michela Manzotti, & G. Viale. (2001). Monoclonal proliferation of germinal center cells (incipient follicular lymphoma) in an axillary lymph node of a melanoma patient. Human Pathology. 32(12). 1410–1413. 17 indexed citations

14.

Castellani, Patrizia, Alessandra Dorcaratto, Antonio Pau, et al.. (2000). The Angiogenesis Marker ED-B+ Fibronectin Isoform in Intracranial Meningiomas. Acta Neurochirurgica. 142(3). 277–282. 11 indexed citations

15.

Hellquist, Henrik, et al.. (1997). Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 andbcl-2 expression and ofin situ end labelling (TUNEL). The Journal of Pathology. 181(3). 323–329. 39 indexed citations

16.

Hellquist, Henrik, et al.. (1996). Bcl-2 immunoreactivity in salivary gland neoplasms is unrelated to the expression of mRNA for natural killer cell stimulatory cytokines interleukin (IL)-2 and IL-12. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 429-429(2-3). 149–58. 1 indexed citations

17.

Bossi, Paola, G. Viale, Arthur K.C. Lee, et al.. (1995). Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations.. PubMed. 55(21). 5049–53. 206 indexed citations

18.

Karlsson, Mats G., et al.. (1995). Nasal Messenger RNA Expression of Interleukins 2, 4, and 5 in Patients with Allergic Rhinitis. Diagnostic Molecular Pathology. 4(2). 85–92. 12 indexed citations

19.

Bòsari, Silvano, et al.. (1993). p53 accumulation in ovarian carcinomas and its prognostic implications. Human Pathology. 24(11). 1175–1179. 89 indexed citations

20.

Pegoraro, Valeria, Walter Artibani, Antonello Calabrò, et al.. (1988). Sarcomatous Carcinoma of the Kidney Presenting as Spontaneous Retroperitoneal Hemorrhage. European Urology. 14(5). 417–421. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact